Cite
HARVARD Citation
Pithadia, D. et al. (2020). Dermatological adverse events associated with use of oral mechanistic target of rapamycin inhibitors in a cohort of individuals with tuberous sclerosis complex. British journal of dermatology. pp. 588-589. [Online].